QNCX (Quince Therapeutics, Inc. Common Stock) Stock Analysis - Analyst Ratings
Quince Therapeutics, Inc. Common Stock (QNCX) is a publicly traded Healthcare sector company. As of May 21, 2026, QNCX trades at $1.09 with a market cap of $16.22M and a P/E ratio of -0.64. QNCX moved +1.40% today. Year to date, QNCX is -96.22%; over the trailing twelve months it is -89.41%. Its 52-week range spans $0.79 to $45.50. Rallies surfaces QNCX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
What do analysts rate QNCX?
The average price target is $0.00.
QNCX Key Metrics
Key financial metrics for QNCX
Metric
Value
Price
$1.09
Market Cap
$16.22M
P/E Ratio
-0.64
EPS
$-1.68
Dividend Yield
0.00%
52-Week High
$45.50
52-Week Low
$0.79
Volume
21.60K
Avg Volume
0
Revenue (TTM)
$0
Net Income
$-80.77M
Gross Margin
0.00%
QNCX Analyst Consensus
QNCX analyst coverage data. Average price target: $0.00.
